Here’s a breakdown of key stocks likely to make headlines today:
Bajaj Finance: The company saw its customer base grow to 92.09 million in the September 2024 quarter, up from 76.56 million last year. Its assets under management (AUM) rose by 29% to ₹3.73 lakh crore, and new loans booked increased by 14%. The deposits book grew by 21%, reaching ₹66,100 crore, with a net liquidity surplus of ₹20,100 crore.
HDFC Bank: BNP Paribas sold 43.75 lakh shares of HDFC Bank at ₹1,726.2 per share, totaling ₹755.3 crore. Morgan Stanley and Citigroup were major buyers, acquiring 17.5 lakh and 26.25 lakh shares, respectively.
Reliance Power: The company’s board approved raising up to $500 million (₹4,200 crore) through Foreign Currency Convertible Bonds (FCCBs) with an annual interest rate of 5%. The board also cleared a new Employee Stock Option Scheme (ESOS) for its staff.
Bank of Baroda: The bank’s global business grew by 10.23% YoY, reaching ₹25.06 lakh crore in Q2 2024. Deposits increased by 9.11% YoY, while advances surged by 11.60%.
M&M Financial Services: Total disbursements dropped slightly by 1% in Q2 FY25. Collection efficiency remained stable at 96%, while Stage-3 assets decreased to 3.8%.
BSE: The Bombay Stock Exchange will stop issuing weekly index derivatives for Sensex 50 and Bankex starting mid-November 2024. Existing contracts will remain valid until expiration, but no new contracts will be issued.
JTL Industries: The company approved splitting its 19.65 crore equity shares of ₹2 each into 39.30 crore shares of ₹1 each. The record date for this split will be announced later.
Refex Industries: The company plans to raise up to ₹927.81 crore through a preferential issue of shares and convertible warrants. These funds will be used for investments, capital expenditures, loan repayments, and other needs.
Premier Polyfilm: The artificial leather manufacturer is set to announce the record date for splitting its shares on October 14, 2024. The company will also release its quarterly financial results on the same date.
Biocon: Biocon Biologics refinanced $1.1 billion in long-term debt through US dollar bonds and new syndicated loans. This refinancing strengthens the company’s liquidity, pushing back a $250 million repayment by five years.
This roundup highlights stocks that could see significant market action today.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
